Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Yogi Hsuan?

Yogi Hsuan

Chief Executive Officer

Meridigen Biotech co

Email: y***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Meridigen Biotech co

Company Description

Meridigen is a biotechnology start-up company located in Greater China area including Taiwan and China. Meridigen is a drug discovery and translational research and development organization primarily focused on the discovery and development of molecular target... more.

Find other employees at this company (23)

Background Information

Employment History

Executive Director

Elevant BioPharma


Web References(3 Total References)


About Us - MANAGEMENT

www.elevantbiopharma.com [cached]

Yogi Hsuan, Executive Director of Board
Mr. Hsuan graduated from Shanghai Jiao Tong University (Master of medicine), he is an experienced practicing physician and acupuncturist, as well as an expert in stem cell, traditional Chinese medicine and Western medicine. Mr. Hsuan has over 10-year experience in clinical and stem cell research studies. He owns many patents for the method of expanding and culturing stem cells in vitro. In 2011, Mr. Hsuan founded and serves as the General Manager of Vital First, a financial management company with the objectives to support start-up biotechnology innovative projects from academic and research institutions, as well as industrial sectors, with good potential to be quickly transformed into commercially available products for patients in need. Vital First has formed strategic alliance with other VC groups in Taiwan, including Fortune Venture Investment Group, and Shin Kong Capital Management (SKCM). Mr. Yogi Hsuan is the CEO of Meridigen Biotech, a stem cell research company, and Meribank, a stem cell storage bank.


Meridigen Biotech Co.,

www.meridigen.com [cached]

General Manager: Yogi Hsuan, ???
Mr. Hsuan graduated from Shanghai Jiao Tong University (Master of medicine), he is an experienced practicing physician and acupuncturist, as well as an expert in hair follicle stem cell, traditional Chinese medicine and Western medicine. Mr. Hsuan has over 10-year experience in clinical and stem cell research studies. He owns many patents for the method of expanding and culturing stem cells in vitro. He is also a General Manager of cell technology of BioFirst Biomedical Group. In 2011, Mr. Hsuan started Vital First, a financial management company with the objectives to support start-up biotechnology innovative projects from academic and research institutions, as well as industrial sectors, with good potential to be quickly transformed into commercially viable products for the welfare of mankind. Vital First has formed strategic alliance with other VC groups in Taiwan, such as BioFirst Biomedical Group, Fortune Venture Investment Group, and Shin Kong Capital Management (SKCM).


Meridigen Biotech Co.,

www.meridigen.com [cached]

1.Feb 25, 2013: Mr. Yogi Hsuan, General Manager of Meridigen and the son of the Emeritus Vice Chairman of UMC (United Microelectronics Corp.), John Hsuan announced today that Meridigen has licensed in the Anti-CD3 Collabody (an anti-CD3 collagen scaffold antibody) from Industrial Technology and Research Institute (ITRI).
Yogi Hsuan, General Manager of Meridigen stated that there are more than 10 biotechnology and pharmaceutical companies had expressed interests to get involved in the building of the Biomedical Park. (Economic Daily News)


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory